BIO-CAT Microbials Receives Letter of No Objection from the FDA for OPTI-BIOME MB40® News BIO-CAT Microbials Receives Letter of No Objection from the FDA for OPTI-BIOME MB40®
BIO-CAT Continues Capital Investment with Addition and Qualification of Two New Stability Chambers News BIO-CAT Continues Capital Investment with Addition and Qualification of Two New Stability Chambers
Recent Comments